(±)-trans-dihydroxy-7,8-dihydrobenzo(a)pyrene (BP-7,8-diol) and 9-hydroxybenzo(a)pyrene (9-OH-BP) were metabolized by rat liver microsomes in the presence of calf thymus DNA, resulting in preferential DNA binding of fluorescent (+)-anti-BP-7,8-diol-9,10-epoxide (BPDE) and 9-OH-BP-4,5-epoxide, respectively. When the DNA is denatured the fluorescence intensities of the bound metabolites change in a characteristic manner. Fluorescence decay measurements show that the intensity changes are due to changes in lifetimes of the excited states. Model substances for the bound metabolites were studied in solvents of different polarity. We found that the fluorescence changes observed after denaturation of the DNA may be explained as solvent polarity effects, so that denaturation forces the bound metabolites from a more hydrophobic environment to a hydrophilic one. Fluorescence depolarization studies as a function of temperature in combination with previous linear dichroism studies show that both BPDE and 9-0H-BP-4,S-epoxide form rigidly associated complexes with native DNA.
References
1.
1. Sims P. Grover PL (1974): Epoxides of polycyclic aromatic hydrocarbons. Metabolism and carcinogenesis.Adv. Cancer Res.20: 165–274.
2.
2. Heidelberger C (1975): Chemical carcinogenesis.Ann. Rev. Biochem.44: 79–127.
3.
3. Gelboin HV (1980): Benzo(a)pyrene metabolism, activation and carcinogenesis: role and regulation of mixed function oxidases and related systems.Physiol. Rev.60: 1107–1166.
4.
4. Ashurst SW, Cohen GM (1981): In vivo formation of benzo(a)pyrene diol epoxide-deoxyadenosine adducts in the skin of mice susceptible to benzo(a)pyrene induced carcinogenesis.Int. J. Cancer27: 357–364.
5.
5. Boroujerdi M, Kung HC, Wilson AGE, Anderson MW (1981): Metabolism and DNA-binding of benzo(a)pyrene in vivo in the rat.Cancer Res.41: 951–957.
6.
6. Deckers-Schmelze B, Klaus E. Kahl R. Kahl GF (1978): Binding of benzo(a)pyrene metabolites to cellular DNA in perfused rat lungs.Naunyn-Schmiedberg's Arch. Pharmacol.303: 303–307.
7.
7. Jernström B, Orrenius S, Undeman O, Gräslund A, Ehrenberg A (1978): Fluorescence study of DNA-binding metabolites of benzo(a)pyrene formed in hepatocytes isolated from 3-methylcholanthrene-treated rats.Cancer Res.38: 2600–2607.
8.
8. Jernström B, Vadi H, Orrenius S (1978): Formation of DNA-binding products from isolated benzo(a)-pyrene metabolites in rat liver nuclei.Chem. Biol. Interact.20: 311–321.
9.
9. King HWS, Osborne MR, Beland FA, Harvey RG, Brookes P (1976): (±)-7α,8β-dihydroxy-9β,10β-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene is an intermediate in the metabolism and binding to DNA of benzo(a)pyrene. Proc. Natl. Acad. Sci. USA73: 2679–2681.
10.
10. King HWS, Thompson MH, Brookes P (1976): The role of 9-hydroxybenzo(a)-pyrene in the microsome mediated binding of benzo(a)pyrene to DNA.Int. J. Cancer18: 339–344.
11.
11. Shen AL. Fahl WE, Jefcoate CR (1980): Metabolism of benzo(a)pyrene by isolated hepatocytes and factors affecting covalent binding of benzo(a)pyrene metabolites to DNA in hepatocytes of microsomal systems.Arch. Biochem. Biophys.204: 511–523.
12.
12. Shinohara K, Cerruti PA (1977): Formation of benzo(a)pyrene DNA adducts in peripheral human lung tissue.Cancer. Lett.3: 303–309.
13.
13. Sims P, Grover PL, Swaisland A, Pal K, Hewer A (1974): Metabolic activation of benzo(a)pyrene proceeds by a diolepoxide.Nature252: 226–228.
14.
14. Vigny P. Ginot YM, Kindts M, Cooper CS, Grover PL. Sims P (1980): Fluorescence spectral evidence that benzo(a)pyrene is activated by metabolism in mouse skin to a diol-epoxide and a phenol-epoxide.Carcinogenesis1: 945–950.
15.
15. Kapitulnik J, Levin W, Yagi H, Jerina DM, Conney AH (1976): Lack of carcinogenicity of 4-, 5-, 6-, 7-, 8-, 9-, and 10-hydroxybenzo(a)pyrene on mouse skin.Cancer Res.36: 3625–3628.
16.
16. Kapitulnik J, Levin W, Conney AH, Yagi H, Jerina DM (1977): Benzo(a)pyrene-7,8-dihydrodiol is more carcinogenic than benzo(a)pyrene in newborn mice.Nature266: 378–380.
17.
17. Levin W, Wood AW, Yagi H, Jerina DM, Conney AH (1976): (±)-trans-7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene: a potent skin carcinogen when applied topically to mice.Proc. Natl. Acad. Sci. USA73: 3867–3871.
18.
18. Slaga TJ, Bracken WM, Dresner S, Levin W, Yagi H, Jerina DM. Conney AH (1978): Skin tumour-initiating activities of the twelve isomeric phenols of benzo(a)pyrene.Cancer Res.38: 678–687.
19.
19. Buening MK, Wislocki PG, Levin W, Yagi H, Thakker DR. Akagi H, Koreeda M, Jerina DM, Conney AH (1978): Tumorigenicity of the optical enentiomers of the diastereoisomeric benzo(a)pyrene-7,8-diol-9,10-epoxides in newborn mice: exceptional activity of (+)-7β,8α-dihydroxy-9α,10α-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene.Proc. Natl. Acad. Sci. USA75: 5358–5361.
20.
20. Slaga TJ, Bracken WJ, Gleason G, Levin W, Yagi H, Jerina DM, Conney AH (1979): Marked differences in the skin tumour-initiating activities of the optical enantiomers of the diasterioisomeric benzo(a)pyrene-7,8-diol-9,10-epoxides.Cancer Res.39: 67–71.
21.
21. Robertson JA, Nordenskjöld M, Jernström B: (1984) The identification of bases in DNA involved in covalent binding of the reactive metabolite of 9-hydroxybenzo(a)pyrene. Carcinogensis5:821–826.
22.
22. Straub KM, Meehan T, Burlingame AL, Calvin M (1977): Identification of the major adducts formed by reaction of benzo(a)pyrene diol epoxide with DNA in vitro.Proc. Natl. Acad. Sci. USA74: 5285–5289.
23.
23. Meehan T, Straub K (1979): Double-stranded DNA stereo-selectively binds benzo(a)pyrene diol epoxides.Nature277: 410–412.
24.
24. Weinstein IB, Jeffrey AH, Leffler S, Pulkabrek P, Yamasaki H, Grunberger D (1978): Interactions between polycyclic aromatic hydrocarbons and cellular macromolecules in Polycyclic Hydrocarbons and Cancer. Vol. 2. HV Gelboin and POP Ts'O (editors). Academic Press, New York, pp. 3–36.
25.
25. Heisig V, Santella R, Cortez C, Harvey RG, Jeffrey A (1983): 9-hydroxybenzo(a)pyrene-4,5-oxide: its role in modification of DNA by benzo(a)pyrene. Proc. Am. Assoc. Cancer Res.24:68.
26.
26. Geacintov ME, Gagliano A, Ivanovic V, Weinstein IB (1978): Electric linear dichroism study on the orientation of benzo(a)pyrene-7, 8-dihydrodiol-9,10-oxide covalently bound to DNA.Biochemistry17: 5256–5262.
27.
27. Hogan ME, Dattagupta N, Whitlock Jr JP (1981): Carcinogen-induced alterations of DNA structure.J. Biol. Chem.256: 4504–4513.
28.
28. Undeman O, Lycksell P-O, Gräslund A, Astlind T, Ehrenberg A, Jernström B, Tjerneld F, Nordén B (1983): Covalent complexes of DNA and two stereoisomers of benzo(a)pyrene-7,8-dihydrodiol-9, 10-epoxide studied by fluorescence and linear dichroism.Cancer Res.43: 1851–1860.
29.
29. Jernström B, Lycksell P-O, Gräslund A, Ehrenberg A, Nordén B (1983): Spectroscopic studies of benzo(a)pyrene-7,8-dihydrodiol-9,10-epoxides covalently bound to DNA in Extrahepatic Drug Metabolism and Chemical Carcinogenesis. J Rydström. J Montelius and M Bengtsson (editors). Elsevier, Amsterdam, pp. 469–477.
30.
30. Ernster L, Siekevitz L, Palade G (1962): Enzyme-structure relationships in the endoplasmic reticulum of rat liver.J. Cell Biol.15: 541–562.
31.
31. Chen RF, Bowman RL (1965): Fluorescence polarization: measurement with ultraviolet-polarizing filters in a spectrophotofluorometer.Science147: 729–732.
32.
32. Olmsted III J,Kearns DR (1977): Mechanism of ethidium bromide fluorescence enhancement on binding to nucleic acids.Biochemistry16: 3647–3654.
33.
33. LePecq JB, Paoletti C (1967): A fluorescent complex between ethidium bromide and nucleic acids. Physical-chemical characterization.J. Mol. Biol.27: 87–106.
34.
34. Dale RE, Eisinger J (1975): Polarized excitation energy transfer in Biochemical Fluorescence. Vol. 1. RF Chen and H Edelhoch (editors). Marcel Dekker, New York, pp. 215–284.
